Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorPearson, Alanen
dc.contributor.advisorCyna, Allan Michaelen
dc.contributor.authorFroessler, Bernden
dc.description.abstractBACKGROUND Iron deficiency anaemia (IDA) is a common condition in patients presenting for surgery and is found in up to 75% of non-cardiac surgical patients. Pre-operative haemoglobin (Hb) is a strong predictor of transfusion requirement and it should, as part of a comprehensive blood conservation approach, be optimised whenever possible. Treatment options for iron deficiency anaemia include oral and intravenous iron or red blood cell transfusion. That both, anaemia and red blood cell (RBC) transfusion expose the patient to unnecessary risks is supported by an ever-increasing body of evidence. Consequently, allogeneic RBC transfusion should be avoided whenever possible and alternative treatment modalities which optimize the patient’s own red cell mass should be exhausted. However, anxiety over the short and long term effects of intravenous iron have limited its more widespread use. Newer dextran-free compounds, however, provide a safer treatment option. OBJECTIVE The objective of this systematic review was to critically appraise, synthesise and present the best available evidence related to the effectiveness and economic aspects of intravenous iron administration on the correction of iron deficiency anaemia in the peri-operative period. DATA SOURCES A comprehensive search was undertaken on major electronic databases from 2001 to 2012. The search was conducted in English, German, Italian and Dutch. REVIEW METHODS Randomized controlled trials, quasi-randomized controlled trials and quasi-experimental studies were included in the review. Critical appraisal and data extraction were undertaken using the Joanna Briggs Institute critical appraisal instrument and the standard data extraction form for evidence of effectiveness. Anaemia correction was as defined by study authors RESULTS The quantitative component of the review identified two randomized controlled trials for inclusion. One study of 76 patients with menorrhagia evaluated the effectiveness of pre-operative intravenous (IV) iron compared with oral iron in anaemic patients scheduled for surgery – the nature of which was not reported, aiming for a 1 g/L haemoglobin increase preoperatively. The intravenous iron group had greater increases in the Hb level than the oral iron group (3.0 vs. 0.8 g/dl, respectively; p < 0.0001). One other study evaluated the effectiveness of pre-operative intravenous (IV) iron compared with placebo in patients with bowel cancer scheduled for resectional surgery, looking at haemoglobin changes between recruitment and day of admission. A small subgroup of these patients was anaemic but no difference was demonstrated in haemoglobin changes between the groups. One additional RCT was found examining the effectiveness of IV iron in cardiac surgical patients, but full text examination and appraisal revealed that the majority of patients enrolled in these studies were not anaemic. The search for the economic component of the review revealed no randomized controlled trials examining the cost effectiveness of preoperative correction of iron deficiency anaemia with intravenous iron CONCLUSIONS Our review found insufficient data to make firm conclusions about the efficacy of pre-operative intravenous iron administration for the correction of anaemia based on clinical trial settings. Neither could we establish firm conclusions on the potential cost savings due to intravenous iron supplementation. IMPLICATIONS FOR PRACTICE There is inadequate RCT evidence at present to guide clinical practice. IMPLICATIONS FOR RESEARCH Our study found insufficient data to make firm conclusions about the efficacy, safety and cost effectiveness of pre-operative intravenous iron administration for the correction of anaemia pre-operatively. Adequately powered RCTs are required that evaluate and report the efficacy, safety and potential cost savings of intravenous iron administration as a treatment modality for iron deficiency anaemia.en
dc.subjectPre-operative anaemia; iron deficiency; intravenous iron; oral iron; blood transfusion; adverse effects; cost-benefit; cost effectiveness; cost-utilityen
dc.titlePre-operative anaemia management with intravenous iron: a systematic review.en
dc.contributor.schoolThe Joanna Briggs Instituteen
dc.contributor.schoolSchool of Translational Health Scienceen
dc.provenanceThis electronic version is made publicly available by the University of Adelaide in accordance with its open access policy for student theses. Copyright in this thesis remains with the author. This thesis may incorporate third party material which has been used by the author pursuant to Fair Dealing exceptions. If you are the owner of any included third party copyright material you wish to be removed from this electronic version, please complete the take down form located at:
dc.description.dissertationThesis (M.Phil.) -- University of Adelaide, School of Translational Health Science, 2013en
Appears in Collections:Research Theses

Files in This Item:
File Description SizeFormat 
01front.pdf203.4 kBAdobe PDFView/Open
02whole.pdf411.3 kBAdobe PDFView/Open
  Restricted Access
Library staff access only269.66 kBAdobe PDFView/Open
  Restricted Access
Library staff access only459.41 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.